samedan logo
 
 
spacer
home > pmps > summer 2021 > welcome to the parenteral technology supplement with pda
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Welcome to the Parenteral Technology Supplement with PDA

PDA is pleased, once again, to have the opportunity to contribute to the PMPS’ Parenteral Technology Supplement. The annual Universe of Pre-Filled Syringes and Injection Devices Conference, which alternates between the US and Europe, is always an excellent opportunity to bring attendees up to speed on the latest developments in pre-filled syringes and other injection devices. PDA’s largest conference, which will be held in digital format for the second time, regularly brings together hundreds of experts from across the world to exchange ideas and learn from one another.

Like PDA, PMPS addresses the global community active in this sector; this supplement supports the innovation in the field of injectable drugs.

It is important to emphasise that new products and technological progress can only come from the cooperation of all stakeholders. This includes not only pharma companies, suppliers, and service providers, but also consultants, academic research institutions, and, last but not least, regulatory authorities.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Falk Klar PhD, Vice President, PDA Europe
spacer
Falk Klar
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Orbit Discovery Awarded Innovate UK Grant to Expand High Throughput Cell-Based Functional Screening Platform Capabilities in Peptide Drug Discovery

Oxford, United Kingdom, 13th June, 2022: Orbit Discovery Ltd., (“Orbit”) a privately held biopharmaceutical company focused on discovering candidate peptide therapeutics harnessing proprietary affinity and cell-based functional screening platforms, has been awarded a Smart grant by Innovate UK, the UK’s innovation agency. Totalling £472,000, the grant will facilitate the implementation of droplet-based microfluidics for cell-based functional screening and significantly expand the capabilities and throughput of Orbit’s peptide display platform. The project aims to advance the discovery of peptide therapeutic candidates including the most challenging of drug targets by improving overall process efficiency whilst reducing the risk and associated costs.
More info >>

White Papers

Finding the Right End-to-End Safety Solution for Your Needs

Bioclinica

With upcoming changes, including the implementation of the International Conference on Harmonisation (ICH) E2B(R3) Electronic Transmission of Individual Case Safety Report and Identification of Medicinal Products (IDMP) standards, the current state of safety reporting can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets regarding the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.
More info >>

 
Industry Events

Connect in Pharma

14-15 September 2022, Plaexpo, Geneva, Switzerland

The new event driving innovation for pharma and biopharma businesses, Connect in Pharma will unite key players in Pharmaceutical and Biopharmaceutical packaging and production in Geneva on 14 – 15 September 2022.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement